The Promise and Perils of Diversity Action Plans for Clinical Trials

被引：1

作者：

Varma, Tanvee ^{[1
]}

Bierer, Barbara E. ^{[1
,2
]}

Hantel, Andrew ^{[2
,3
]}

机构：

[1] Brigham & Womens Hosp, Boston, MA USA

[2] Harvard Med Sch, Boston, MA USA

[3] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2024年 / 332卷 / 21期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1001/jama.2024.18225

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1787 / 1788

页数：2

共 5 条

[1]

[Anonymous], ?About us"

[2]

[Anonymous], 2022, 117th US Cong

[3] Racial and ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemia [J].

Hantel, Andrew ;

Brunner, Andrew M. ;

Plascak, Jesse J. ;

Uno, Hajime ;

Varela, Juan C. ;

Luskin, Marlise R. ;

Rebbeck, Timothy R. ;

Stone, Richard M. ;

Lathan, Christopher S. ;

Deangelo, Daniel J. ;

Abel, Gregory A. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (07) :1178-1184

[4] Racial Disparities in Receipt of Guideline-Concordant Care for Early-Onset Colorectal Cancer in the United States [J].

Nogueira, Leticia M. ;

May, Folasade P. ;

Yabroff, K. Robin ;

Siegel, Rebecca L. .

JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (12) :1368-1377

[5]

U.S. Food and Drug Administration, 2024, DIVERSITY ACTION PLA

← 1 →